We are excited to introduce Dr. Sara Tolaney, a leading expert in breast oncology, as our next oncoinfluencer.
Dr. Sara Tolaney is active on X/Twitter and LinkedIn, where she shares her insights and expertise in breast cancer research and treatment. As the Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, she also serves as the Associate Director of the Susan F. Smith Center for Women’s Cancers and is a Senior Physician at Dana-Farber. Additionally, she is an Associate Professor of Medicine at Harvard Medical School.
Follow Dr. Sara Tolaney on X/Twitter and LinkedIn to stay informed about her groundbreaking work and contributions to advancing breast cancer therapies.
About Dr. Sara Tolaney
Dr. Tolaney’s research focuses on the development of novel therapies for breast cancer, with an emphasis on creating more effective and less toxic treatment approaches. Her work has shown that a relatively low-risk regimen can be beneficial for women with early-stage node-negative HER2-positive cancers, findings that have been incorporated into national and international guidelines.
She has developed several follow-up studies investigating novel approaches to early-stage HER2-positive disease and has played a significant role in the advancement of CDK 4/6 inhibitors, antibody-drug conjugates, and immunotherapy in breast cancer. With over 150 peer-reviewed publications in leading scientific journals, Dr. Tolaney is a recognized leader in her field.
Her contributions have earned her several prestigious awards, including the Lee M. Nadler “Extra Mile” Award and the Innovation Award for Clinical Faculty.
Stay tuned for more inspiring profiles in our oncoinfluencer series, and don’t miss our previous features highlighting influential voices in the oncology community!
